Immune evasion by Kaposi's sarcoma-associated herpesvirus

被引：105

作者：

Coscoy, Laurent ^{[1
]}

机构：

[1] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA

来源：

NATURE REVIEWS IMMUNOLOGY | 2007年 / 7卷 / 05期

关键词：

D O I：

10.1038/nri2076

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

To efficiently establish a persistent infection, Kaposi's sarcoma-associated herpesvirus ( KSHV; also known as HHV8) dedicates a large amount of its coding potential to produce proteins that antagonize the immune system of its host. These viral immunomodulators interfere with both the innate and adaptive immune responses and most of them are homologous to cellular proteins, suggesting that they have been pirated from the host during viral evolution. In this Review, I present recent advances in the understanding of immune evasion by KSHV, with a particular focus on the virally encoded modulators of immune responses that are unique to this virus.

引用

页码：391 / 401

页数：11

共 124 条

[101] Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease [J].

Staskus, KA ;

Sun, R ;

Miller, G ;

Racz, P ;

Jaslowski, A ;

Metroka, C ;

Brett-Smith, H ;

Haase, AT .

JOURNAL OF VIROLOGY, 1999, 73 (05) :4181-4187

[102] Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (Spindle) tumor cells [J].

Staskus, KA ;

Zhong, WD ;

Gebhard, K ;

Herndier, B ;

Wang, H ;

Renne, R ;

Beneke, J ;

Pudney, J ;

Anderson, DJ ;

Ganem, D ;

Hasse, AT .

JOURNAL OF VIROLOGY, 1997, 71 (01) :715-719

[103] KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells [J].

Stine, JT ;

Wood, C ;

Hill, M ;

Epp, A ;

Raport, CJ ;

Schweickart, VL ;

Endo, Y ;

Sasaki, T ;

Simmons, G ;

Boshoff, C ;

Clapham, P ;

Chang, Y ;

Moore, P ;

Gray, PW ;

Chantry, D .

BLOOD, 2000, 95 (04) :1151-1157

[104] Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression [J].

Sun, R ;

Lin, SF ;

Staskus, K ;

Gradoville, L ;

Grogan, E ;

Haase, A ;

Miller, G .

JOURNAL OF VIROLOGY, 1999, 73 (03) :2232-2242

[105] Transcriptional analysis of latent and inducible Kaposi's sarcoma-associated herpesvirus transcripts in the K4 to K7 region [J].

Taylor, JL ;

Bennett, HN ;

Snyder, BA ;

Moore, PS ;

Chang, Y .

JOURNAL OF VIROLOGY, 2005, 79 (24) :15099-15106

[106] Effective vaccination against long-term gammaherpesvirus latency [J].

Tibbetts, SA ;

McClellan, JS ;

Gangappa, S ;

Speck, SH ;

Virgin, HW .

JOURNAL OF VIROLOGY, 2003, 77 (04) :2522-2529

[107] Surface downregulation of major histocompatibility complex class I, PE-CAM, and ICAM-1 following de novo infection of endothelial cells with Kaposi's sarcoma-associated herpesvirus [J].

Tomescu, C ;

Law, WK ;

Kedes, DH .

JOURNAL OF VIROLOGY, 2003, 77 (17) :9669-9684

[108] Human herpesvirus 8 interleukin-6 (vIL-6) signals through gp130 but has structural acid receptor-binding properties distinct from those of human IL-6 [J].

Wan, XY ;

Wang, HL ;

Nicholas, J .

JOURNAL OF VIROLOGY, 1999, 73 (10) :8268-8278

[109] Modulation of human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus replication and transcription activator transactivation by interferon regulatory factor 7 [J].

Wang, JZ ;

Zhang, J ;

Zhang, LW ;

Harrington, W ;

West, JT ;

Wood, C .

JOURNAL OF VIROLOGY, 2005, 79 (04) :2420-2431

[110] Primary human herpesvirus 8 infection generates a broadly specific CD8+ T-cell response to viral lytic cycle proteins [J].

Wang, QJ ;

Jenkins, FJ ;

Jacobson, LP ;

Kingsley, LA ;

Day, RD ;

Zhang, ZW ;

Meng, YX ;

Pellet, PE ;

Kousoulas, KG ;

Baghian, A ;

Rinaldo, CR .

BLOOD, 2001, 97 (08) :2366-2373

← 4 5 6 7 8 9 10 11 12 13 →